Data / Form D filings / Xenon Ophthalmics Inc
Xenon Ophthalmics Inc: Form D filing
Xenon Ophthalmics Inc, a biotechnology company in Jersey City, NJ, filed a Form D with the SEC in 2026. The latest, on October 6, 2026, reports $3.3 million sold of an offering with no set size to 20 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 525 Washington Blvd suite 300, Jersey City, NJ, 07310
- Phone
- (973) 619-4071
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1988832
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 6 | Amendment | Indefinite | $3,315,004 | 20 | Aug 15 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Zeshan Khan | Executive Officer, Director | |
| Steve Susanibar | Executive Officer | |
| Robert Gilligan | Director | |
| Bruce Stark | Promoter | |
| David Singelyn | Director |
Other biotechnology companies in New Jersey that filed recently
- Ensho Therapeutics, Inc. $7.3 million · Oct 15
- LISATA THERAPEUTICS, INC. $351.9 million · Oct 2
Every Form D from the week of Oct 5 · All recent filings in New Jersey · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Xenon Ophthalmics Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.